Applying science to care.

Medavera identifies gaps in knowledge and care, methodically researches the subject matter, identifies the top experts to guide the content, and then utilizes a format that will provide the best learning opportunity. We are always looking for new teaching methods and technologies in order to offer stimulating and actionable medical education. Medical education must be meaningful to become applied to clinical practice. Great content, respected leaders, and interesting formats create successful interactions and learning.

Reducing Opioids in Surgical Pain Management:
Exploring New Perioperative and Postoperative Strategies

Wednesday, April 18, 2018
5:00 - 6:00 pm ET

Register online at

The U.S. opioid epidemic continues and strategies are needed to reduce their use before and after surgery, and for long-term pain management. This webinar presented by Drs. R. Corey Waller, Jay Kuchera, Sarah E. Rebstock, and Daniel H. Sajewski is accredited for physicians, nurses, and pharmacists.

Complimentary CME & CE Credits. There is no charge for the program or certificate, but registration is required for the webinar, access to the slides, and online post-test CME assessment.

Planned and developed by Medavera, Inc. and supported by an educational grant from Cumberland Pharmaceuticals, Inc.

Medavera, Inc. has partnered with Envision to provide this program to healthcare professionals.

(Reuters Health) - A dash of cumin or dill might help convince high school students to load up their plate with vegetables during lunchtime in the cafeteria, a small study suggests.... LONDON, March 16 (Reuters) - A huge and deadly outbreak of listeria in South Africa could alter the country's approach to food-borne disease and prompt improvements in food safety standards, a leading health official said on Friday.... (Reuters Health) - People who have slightly elevated blood sugar that’s not high enough for a diabetes diagnosis may still have a higher risk of heart and kidney disease than individuals with normal blood sugar, a U.S. study suggests.... NEW YORK (Reuters) - In 2014, as Jonathan Rubin and Ian Laird considered investing in the booming U.S. cannabis industry, they hit a problem: How to value pot start-ups with little verified data on the price of the weed itself?... Reuters Health - Exercise training helps improve daily life for obese adults with asthma, a new study found.... COPENHAGEN (Reuters) - Lundbeck agreed to buy Prexton Therapeutics, a specialist in treatments for brain disorders, in a deal potentially worth $1.1 billion, the Danish drugmaker said on Friday.... Reuters Health - Almost half of small employers that charge tobacco users extra for their health insurance don’t offer wellness programs to help employees stop smoking, according to a recent study.... BOSTON (Reuters) - Massachusetts' top court on Friday opened the door for consumers to sue Merck & Co Inc and other makers of brand-name drugs over injuries blamed not on their own medications but on generic versions of their treatments made by other companies.... (Reuters) - The U.S. government said on Friday it will pay for certain genetic tests for Medicare-eligible patients with advanced cancer, in a bid to help match patients with the drugs most likely to provide benefit.... WASHINGTON (Reuters) - The U.S. Food and Drug Administration took a fresh step on Thursday towards setting a maximum nicotine level for tobacco products in a bid to lower tobacco-related deaths across the country, saying it would collect public comment and scientific research over the next three months....